| Michelle N Bingham, | |
|
1850 State St, New Albany, IN 47150-4990 | |
| (812) 944-7701 | |
| (812) 981-6505 |
| Full Name | Michelle N Bingham |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1850 State St, New Albany, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043701840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 28218317A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Louisville Hospital | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due to diseases like cancer are also at an increased risk of severe complications from the virus.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
› Verified 6 days ago
| Entity Name | University Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861554438 PECOS PAC ID: 0042123598 Enrollment ID: O20110204000012 |
News Archive
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due to diseases like cancer are also at an increased risk of severe complications from the virus.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
› Verified 6 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due to diseases like cancer are also at an increased risk of severe complications from the virus.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
› Verified 6 days ago
| Entity Name | Aspire Health Medical Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124443403 PECOS PAC ID: 9931332111 Enrollment ID: O20161003002695 |
News Archive
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due to diseases like cancer are also at an increased risk of severe complications from the virus.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle N Bingham, 2700 Stanley Gault Pkwy Ste 129, Louisville, KY 40223-5176 Ph: (502) 253-4917 | Michelle N Bingham, 1850 State St, New Albany, IN 47150-4990 Ph: (812) 944-7701 |
News Archive
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due to diseases like cancer are also at an increased risk of severe complications from the virus.
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
› Verified 6 days ago
Mr. David Melvin Whittaker, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1919 State St Ste 364, New Albany, IN 47150 Phone: 812-949-4767 Fax: 812-948-4338 | |
Sarah E Carpenter, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2109 Green Valley Rd, New Albany, IN 47150 Phone: 812-948-2232 Fax: 812-945-0869 | |
Alexandra Hardin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1950 State St, New Albany, IN 47150 Phone: 812-948-8305 | |
Mrs. Christy Rae Crawley, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 906 Silver St, New Albany, IN 47150 Phone: 502-931-2565 | |
Angela M Gallahar, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1950 State St, New Albany, IN 47150 Phone: 812-948-8305 | |
Ms. Rachel Elizabeth Gould, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2630 Grant Line Rd, New Albany, IN 47150 Phone: 812-945-0145 |